BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Flagship Pioneering Announces Launch of mRNA Cousin eRNA with Laronde

  Over the past year, the world at large has become more familiar with mRNA technology. Now the world will be introduced to a new type of RNA-based medicine called eRNA.

  May 10, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  New COVID-19 Vaccine on the Block Displays Multi-Variant Potential

  The Infectious Disease Research Institute (IDRI), Duke Human Vaccine Institute, and 3M are working together on a potential vaccine that might protect individuals against multiple variants of SARS-CoV-2.

  May 10, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  After Months of Prodding, CDC Updates Guidance on COVID-19 Airborne Transmission

  The CDC says that COVID-19 is an airborne threat, stating that transmission and subsequent infection can occur via inhalation of very fine respiratory droplets and aerosolized particles.

  May 10, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Drug Development

  jCyte Announces Promising Phase IIb Results for Allogeneic Retinal Stem Cell Therapy

  jCyte Inc. presented the results from its Phase IIb study and a detailed analysis of the study’s optical coherence tomography (OCT) data last week at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting.

  May 10, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Business

  With $52 Million Series A, Appia Bio Anticipates a Bright Future in Cell Therapy

  Appia is developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer patients.

  May 10, 2021

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Renal-Focused Alebund Pharma Raises $60 Million in Series B Financing Round

  Shanghai-based Alebund Pharmaceuticals has raised $60 million in a new Series B financing round that will be harnessed to further drive the company’s focus on renal disease.

  May 10, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Business

  Abingworth’s $582 Million Co-Development Fund Will Propel Late-Stage Trials

  London-based venture capital fund Abingworth closed on a new Clinical Co-Development Fund now at $582 million. The fund’s original target was just at $350 million.

  May 10, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  BioNTech Secures Manufacturing Capacity in Asia for mRNA Vaccine and Therapeutics

  BioNTech will open a state-of-the-art manufacturing facility in Singapore to support a global supply of mRNA-based vaccines and therapeutics.

  May 10, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Researchers Concerned Over Long Covid Effects on Communities of Color

  Researchers are now concerned that the same health inequalities that have made certain racial and ethnic groups experience higher infection and death rates also drive disparities in treatment for long Covid.

  May 10, 2021

   · 

  4 min read

   · 

  Kate Goodwin
• 

  Deals

  AbbVie Subsidiary Scoops Up Soliton and Its Cellulite, Tattoo Removal Device

  AbbVie’s Allergan Aesthetics’ most well-known brands right now include BOTOX and CoolSculpting, among others. However, with the company’s latest acquisition, another one might slide its way to the top.

  May 10, 2021

   · 

  2 min read

   · 

  Ellen Bombela